Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
- PMID: 32432977
- PMCID: PMC7448857
- DOI: 10.1080/22221751.2020.1772676
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
Abstract
The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine and oxysophoridine against SARS-CoV-2 in cell culture. We found that all three tested compounds inhibited viral replication in Vero-E6 cells at noncytotoxic concentrations. The antiviral effect of gemcitabine was suppressed efficiently by the cytidine nucleosides. Additionally, combination of gemcitabine with oxysophoridine had an additive antiviral effect against SARS-CoV-2. Our results demonstrate that broad-spectrum antiviral compounds may have a priority for the screening of antiviral compounds against newly emerging viruses to control viral infection.
Keywords: 2019-nCoV; Novel coronavirus; SARS-CoV-2; alkaloid; broad-spectrum antiviral.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7448857/bin/TEMI_A_1772676_F0001_OC.gif)
Similar articles
-
Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections.Phytomedicine. 2021 Jun;86:153440. doi: 10.1016/j.phymed.2020.153440. Epub 2020 Dec 16. Phytomedicine. 2021. PMID: 33376043 Free PMC article.
-
Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.Int J Mol Sci. 2021 Feb 4;22(4):1581. doi: 10.3390/ijms22041581. Int J Mol Sci. 2021. PMID: 33557278 Free PMC article.
-
A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor.Virology. 2009 Feb 5;384(1):242-52. doi: 10.1016/j.virol.2008.11.003. Epub 2008 Dec 5. Virology. 2009. PMID: 19062063 Free PMC article.
-
Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.In Vivo. 2020 Jun;34(3 Suppl):1597-1602. doi: 10.21873/invivo.11949. In Vivo. 2020. PMID: 32503817 Free PMC article. Review.
-
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?Cells. 2020 Sep 15;9(9):2100. doi: 10.3390/cells9092100. Cells. 2020. PMID: 32942671 Free PMC article. Review.
Cited by
-
Benzoindolizidine Alkaloids Tylophorine and Lycorine and Their Analogues with Antiviral, Anti-Inflammatory, and Anticancer Properties: Promises and Challenges.Biomedicines. 2023 Sep 24;11(10):2619. doi: 10.3390/biomedicines11102619. Biomedicines. 2023. PMID: 37892993 Free PMC article. Review.
-
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses.Biomolecules. 2023 Sep 26;13(10):1452. doi: 10.3390/biom13101452. Biomolecules. 2023. PMID: 37892134 Free PMC article. Review.
-
Characterization of norbelladine synthase and noroxomaritidine/norcraugsodine reductase reveals a novel catalytic route for the biosynthesis of Amaryllidaceae alkaloids including the Alzheimer's drug galanthamine.Front Plant Sci. 2023 Aug 30;14:1231809. doi: 10.3389/fpls.2023.1231809. eCollection 2023. Front Plant Sci. 2023. PMID: 37711303 Free PMC article.
-
A study on the effect of natural products against the transmission of B.1.1.529 Omicron.Virol J. 2023 Aug 25;20(1):191. doi: 10.1186/s12985-023-02160-6. Virol J. 2023. PMID: 37626376 Free PMC article. Review.
-
Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets.Pharm Biol. 2023 Dec;61(1):1186-1210. doi: 10.1080/13880209.2023.2241518. Pharm Biol. 2023. PMID: 37605622 Free PMC article. Review.
References
-
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL.. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. DOI:10.1038/s41586-020-2012-7. - DOI - PMC - PubMed
-
- Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG, Jr., Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB.. 2014. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother 58:4885-93. doi: 10.1128/AAC.03036-14 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous